Abstract
Purpose
Because the best possible treatment for venous malformations is unclear, this study systematically reviews the available literature regarding the effectiveness of different treatment options for the patient group. Venous malformations result from incorrect development of the veins during embryogenesis and are present at birth. Venous malformations may exhibit symptoms, such as pain, swelling, and inflammation of the vessel.
Materials and Methods
A systematic literature search in PubMed and Embase was performed. Data regarding the design, participants, intervention and, treatment outcome (success and complications) were extracted. The validity of the studies was assessed with the Cochrane Collaboration’s risk of bias tool.
Results
Thirty-five studies were identified studying the effectiveness of eight treatments: sclerotherapy/embolization with ethanol, gelified ethanol, bleomycin, polidocanol, sodium tetradecyl sulfate (STS), Ethibloc, surgery, and laser therapy. All of the included studies have a high or unclear risk of bias. The average biased reported success rates for ethanol, gelified ethanol, bleomycin, polidocanol, STS, Ethibloc, surgery, and laser therapy were 74, 89, 88, 90, 86, 65, 90, and 94 %, respectively.
Conclusion
Until more valid evidence is available, the choice for treatment remains a shared decision between the patient and a multidisciplinary treatment group. From a cost perspective, sclerotherapy with STS or polidocanol should be the treatment of choice.
Similar content being viewed by others
References
Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69(3):412–422
Boon LM, Ballieux F, Vikkula M (2011) Pathogenesis of vascular anomalies. Clin Plast Surg 38(1):7–19
Ballah D, Cahill AM, Fontalvo L, Yan A, Treat J, Low D et al (2011) Vascular anomalies: what they are, how to diagnose them, and how to treat them. Curr Probl Diagn Radiol 40(6):233–247
Garzon MC, Huang JT, Enjolras O, Frieden IJ (2007) Vascular malformations. Part I. J Am Acad Dermatol 56(3):353–370 quiz 71–74
Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E (2001) Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 21(6):1519–1531
Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK (2012) Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg 68(2):198–201
McCafferty IJ, Jones RG (2011) Imaging and management of vascular malformations. Clin Radiol 66(12):1208–1218
Greene AK, Alomari AI (2011) Management of venous malformations. Clin Plast Surg 38(1):83–93
Higgins JPT, Altman GD (2008) Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions. Cochrane book series. John Wiley & Sons Ltd, England
Barbier C, Martin A, Papagiannaki C, Cottier JP, Lorette G, Herbreteau D (2010) Superficial venous malformations. Presse Med 39(4):471–481
Redondo P, Aguado L (2010) Current management of venous malformations. An Sist Sanit Navar 33(3):297–308
Zheng JW, Zhou Q, Yang XJ, Wang YA, Fan XD, Zhou GY et al (2010) Treatment guideline for hemangiomas and vascular malformations of the head and neck. Head Neck 2(8):1088–1098
Mattassi R (2009) Treatment of venous malformations. In: Mattassi R, Loose DA, Vaghi M (eds) Hemangiomas and vascular anomalies. Springer, Milan, pp 223–230
Puig S, Casati B, Staudenherz A, Paya K (2005) Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 53(1):35–45
Redondo P, Aguado L, Martinez-Cuesta A (2011) Diagnosis and management of extensive vascular malformations of the lower limb. Part II. Systemic repercussions [corrected], diagnosis, and treatment. J Am Acad Dermatol 65(5):909–923 quiz 924
Villavicencio JL, Scultetus A, Lee BB (2002) Congenital vascular malformations: when and how to treat them. Semin Vasc Surg 15(1):65–71
Dompmartin A, Blaizot X, Theron J, Hammer F, Chene Y, Labbe D et al (2011) Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol 21(12):2647–2656
Hu X, Chen D, Jiang C, Jin Y, Chen H, Ma G et al (2011) Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation. Head Neck 33(11):1616–1621
Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH (2003) Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 37(3):533–538
Lee BB, Kim DI, Huh S, Kim HH, Choo IW, Byun HS et al (2011) New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 33(4):764–772
Lee CH, Chen SG (2005) Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plastic Surg 58(8):1073–1078
Lee IH, Kim KH, Jeon P, Byun HS, Kim HJ, Kim ST et al (2009) Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol 10(3):269–276
Orlando JL, Caldas JG, Campos HG, Nishinari K, Wolosker N (2010) Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia. Clinics 65(9):837–840
Orlando JL, Caldas JG, Campos HG, Nishinari K, Wolosker N (2010) Ethanol sclerotherapy of superficial venous malformation: a new procedure. Dermatology 220(4):376–380
Rimon U, Garniek A, Galili Y, Golan G, Bensaid P, Morag B (2004) Ethanol sclerotherapy of peripheral venous malformations. Eur J Radiol 52(3):283–287
Shireman PK, McCarthy WJ, Yao JS, Vogelzang RL (1997) Treatment of venous malformations by direct injection with ethanol. J Vasc Surg 26(5):838–844
Spence J, Krings T, TerBrugge KG, Agid R (2011) Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck 33(1):125–130
Su L, Fan X, Zheng L, Zheng J (2010) Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg 68(7):1622–1627
Svendsen P, Wikholm G, Fogdestam I, Naredi S, Eden E (1994) Instillation of alcohol into venous malformations of the head and neck. Scand J Plast Reconstr Surg 28(4):279–284
Yun WS, Kim YW, Lee KB, Kim DI, Park KB, Kim KH et al (2009) Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg 50(3):581–589 (589 e1)
Li J, Chen J, Zheng G, Liao G, Fu Z, Li J et al (2010) Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region. J Oral Maxillofac Surg 68(9):2258–2266
Zhao JH, Zhang WF, Zhao YF (2004) Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg 33(5):463–466
Zheng JW, Yang XJ, Wang YA, He Y, Ye WM, Zhang ZY (2009) Intralesional injection of pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients. Oral Oncol 45(10):872–876
Zhi K, Wen Y, Li L, Ren W (2008) The role of intralesional pingyangmycin in the treatment of venous malformation of facial and maxillary region. Int J Pediatr Otorhinolaryngol 72(5):593–597
Blaise S, Charavin-Cocuzza M, Riom H, Brix M, Seinturier C, Diamand JM et al (2011) Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review. Eur J Vasc Endovasc Surg 41(3):412–417
Mimura H, Fujiwara H, Hiraki T, Gobara H, Mukai T, Hyodo T et al (2009) Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief. Eur Radiol 19(10):2474–2480
Mimura H, Kanazawa S, Yasui K, Fujiwara H, Hyodo T, Mukai T et al (2003) Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama 57(5):227–234
Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26(4):323–338
Khandpur S, Sharma VK (2010) Utility of intralesional sclerotherapy with 3 % sodium tetradecyl sulphate in cutaneous vascular malformations. Dermatol Surg 36(3):340–346
O’Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B (1997) Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. Am J Roengenol 169(3):723–729
Dubois JM, Sebag GH, De Prost Y, Teillac D, Chretien B, Brunelle FO (1991) Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology 180(1):195–198
Zhong LP, Ow A, Yang WJ, Hu YJ, Wang LZ, Zhang CP (2011) Surgical management of solitary venous malformation in the midcheek region. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 26(4):813–823
Lu X, Ye K, Shi H, Li W, Huang Y, Huang X et al (2011) Percutaneous endovenous treatment of congenital extratruncular venous malformations with an ultrasound-guided and 810-nm diode laser. J Vasc Surg 54(1):139–145
Poetke M, Philipp C, Urban P, Berlien HP (2011) Interstitial laser treatment of venous malformations. Med Laser Appl 16(2):111–119
Sarig O, Kimel S, Orenstein A (2006) Laser treatment of venous malformations. Ann Plast Surg 57(1):20–24
Sidhu MK, Perkins JA, Shaw DW, Bittles MA, Andrews RT (2005) Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol 16(6):879–884 L
Dompmartin A, Vikkula M, Boon LM (2010) Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology 25(5):224–235
Burrows PE, Mason KP (2004) Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 15(5):431–445
Liu Y, Liu D, Wang Y, Zhang W, Zhao F (2009) Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin. J Oral Maxillofac Surg 67(1):98–104
Zochowski CG, Salgado CJ, Jamali AA (2010) Extensive muscle necrosis and infection following treatment of a lower extremity vascular malformation with sotradecol and absolute ethanol. Blood Coagul Fibrinolysis 21(5):480–486
Gelbert F, Enjolras O, Deffrenne D, Aymard A, Mounayer C, Merland JJ (2000) Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients. Neuroradiology 42(9):692–696
Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edstrom S (1997) Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg 31(2):145–150
Jin Y, Lin X, Li W, Hu X, Ma G, Wang W (2008) Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg 47(6):1292–1299
Derby LD, Low DW (1997) Laser treatment of facial venous vascular malformations. Ann Plastic Surg 38(4):371–378
Lapidoth M, Yaniv E, Ben Amitai D, Raveh E, Kalish E, Waner M et al (2005) Treatment of facial venous malformations with combined radiofrequency current and 900 nm diode laser. Dermatol Surg 31(10):1308–1312
Conflict of interest
All authors, C.J.M. van der Vleuten, A. Kater, M.H.W.A. Wijnen, L.J. SchultzeKool, M.M. Rovers, declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Appendix: Search Strategy
Appendix: Search Strategy
Ethanol
-
Search strategy pubmed: (ethanol[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((absolute[Title/Abstract] AND ethanol[Title/Abstract]) AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: (alcohol[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((absolute[Title/Abstract] AND alcohol[Title/Abstract]) AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((“ethanol”[MeSH Terms] OR “ethanol”[All Fields]) AND (“sclerotherapy”[MeSH Terms] OR “sclerotherapy”[All Fields])) AND ((“veins”[MeSH Terms] OR “veins”[All Fields] OR “venous”[All Fields]) AND (“congenital abnormalities”[MeSH Terms] OR (“congenital”[All Fields] AND “abnormalities”[All Fields]) OR “congenital abnormalities”[All Fields] OR “malformation”[All Fields]))
-
Search strategy embase: (ethanol and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (alcohol and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (absolute ethanol and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (absolute alcohol and sclerotherapy and venous malformation).ab.
Bleomycin
-
Search strategy pubmed: (bleomycin[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: (pingyangmycin[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((“bleomycin”[MeSH Terms] OR “bleomycin”[All Fields]) AND (“sclerotherapy”[MeSH Terms] OR “sclerotherapy”[All Fields])) AND ((“veins”[MeSH Terms] OR “veins”[All Fields] OR “venous”[All Fields]) AND (“congenital abnormalities”[MeSH Terms] OR (“congenital”[All Fields] AND “abnormalities”[All Fields]) OR “congenital abnormalities”[All Fields] OR “malformation”[All Fields]))
-
Search strategy pubmed: ((“bleomycetin”[Supplementary Concept] OR “bleomycetin”[All Fields] OR “pingyangmycin”[All Fields]) AND (“sclerotherapy”[MeSH Terms] OR “sclerotherapy”[All Fields])) AND ((“veins”[MeSH Terms] OR “veins”[All Fields] OR “venous”[All Fields]) AND (“congenital abnormalities”[MeSH Terms] OR (“congenital”[All Fields] AND “abnormalities”[All Fields]) OR “congenital abnormalities”[All Fields] OR “malformation”[All Fields]))
-
Search strategy embase: (bleomycine and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (pingyangmycine and sclerotherapy and venous malformation).ab.
Polidocanol
-
Search strategy pubmed: ((venous[Title/Abstract] AND malformation[Title/Abstract]) AND sclerotherapy[Title/Abstract]) AND polidocanol[Title/Abstract]
-
Search strategy pubmed: (aetoxisclerol[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: (((aetoxisklerol[Title/Abstract])) AND (sclerotherapy[Title/Abstract])) AND (venous malformation[Title/Abstract])
-
Search strategy pubmed: (etoxisclerol[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed:((“polidocanol”[Supplementary Concept] OR “polidocanol”[All Fields] OR “aetoxisclerol”[All Fields]) AND (“sclerotherapy”[MeSH Terms] OR “sclerotherapy”[All Fields])) AND ((“veins”[MeSH Terms] OR “veins”[All Fields] OR “venous”[All Fields]) AND (“congenital abnormalities”[MeSH Terms] OR (“congenital”[All Fields] AND “abnormalities”[All Fields]) OR “congenital abnormalities”[All Fields] OR “malformation”[All Fields]))
-
Search strategy embase: (polidocanol and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (aetoxisclerol and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (aetoxisklerol and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (etoxisclerol and sclerotherapy and venous malformation).ab.
STS
-
Search strategy pubmed: ((sodium[Title/Abstract] AND tetradecyl[Title/Abstract] AND sulfate[Title/Abstract]) AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((“sodium tetradecyl sulphate”[All Fields] OR “sodium tetradecyl sulfate”[MeSH Terms] OR (“sodium”[All Fields] AND “tetradecyl”[All Fields] AND “sulfate”[All Fields]) OR “sodium tetradecyl sulfate”[All Fields]) AND (“sclerotherapy”[MeSH Terms] OR “sclerotherapy”[All Fields])) AND ((“veins”[MeSH Terms] OR “veins”[All Fields] OR “venous”[All Fields]) AND (“congenital abnormalities”[MeSH Terms] OR (“congenital”[All Fields] AND “abnormalities”[All Fields]) OR “congenital abnormalities”[All Fields] OR “malformation”[All Fields]))
-
Search strategy pubmed: (sotradecol[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((sodium[Title/Abstract] AND lauryl[Title/Abstract] AND sulfate[Title/Abstract]) AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy: (sodium tetradecyl sulfate and sclerotherapy and venous malformation).ab
-
Search strategy embase: (sotradecol and sclerotherapy and venous malformation).ab.
-
Search strategy embase: (sodium lauryl sulfate and sclerotherapy and venous malformation).ab.
Ethibloc
-
Search strategy pubmed: (ethibloc[Title/Abstract] AND sclerotherapy[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((“alcoholic prolamine solution”[Supplementary Concept] OR “alcoholic prolamine solution”[All Fields] OR “ethibloc”[All Fields]) AND (“sclerotherapy”[MeSH Terms] OR “sclerotherapy”[All Fields])) AND ((“veins”[MeSH Terms] OR “veins”[All Fields] OR “venous”[All Fields]) AND (“congenital abnormalities”[MeSH Terms] OR (“congenital”[All Fields] AND “abnormalities”[All Fields]) OR “congenital abnormalities”[All Fields] OR “malformation”[All Fields]))
-
Search strategy: (ethibloc and sclerotherapy and venous malformation).ab.
Surgery
-
Search strategy pubmed: (surgical[Title/Abstract] AND treatment[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: ((surgical[Title/Abstract] AND treatment[Title/Abstract]) AND (vascular[Title/Abstract] AND surgery[Title/Abstract])) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy embase: (surgery and venous malformation).ab.
Laser
-
Search strategy pubmed: (((laser[Title/Abstract] AND therapy[Title/Abstract]) AND laser[Title/Abstract]) AND treatment[Title/Abstract]) AND (venous[Title/Abstract] AND malformation[Title/Abstract])
-
Search strategy pubmed: (((“laser therapy, low-level”[MeSH Terms] OR (“laser”[All Fields] AND “therapy”[All Fields] AND “low-level”[All Fields]) OR “low-level laser therapy”[All Fields] OR (“laser”[All Fields] AND “therapy”[All Fields]) OR “laser therapy”[All Fields] OR “laser therapy”[MeSH Terms] OR (“laser”[All Fields] AND “therapy”[All Fields])) AND (“lasers”[MeSH Terms] OR “lasers”[All Fields] OR “laser”[All Fields])) AND (“therapy”[Subheading] OR “therapy”[All Fields] OR “treatment”[All Fields] OR “therapeutics”[MeSH Terms] OR “therapeutics”[All Fields])) AND ((“veins”[MeSH Terms] OR “veins”[All Fields] OR “venous”[All Fields]) AND (“congenital abnormalities”[MeSH Terms] OR (“congenital”[All Fields] AND “abnormalities”[All Fields]) OR “congenital abnormalities”[All Fields] OR “malformation”[All Fields]))
Rights and permissions
About this article
Cite this article
van der Vleuten, C.J.M., Kater, A., Wijnen, M.H.W.A. et al. Effectiveness of Sclerotherapy, Surgery, and Laser Therapy in Patients With Venous Malformations: A Systematic Review. Cardiovasc Intervent Radiol 37, 977–989 (2014). https://doi.org/10.1007/s00270-013-0764-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-013-0764-2